Informed Consent for the Use of AI in the Process of Providing Medical Services
Abstract
It has been for several years now that physicians use medical devices based on artificial intelligence (AI) in their professional practice. The use of these tools makes health services more personalized, tailored to the individual characteristics and needs of the patient. There is also a technological possibility for AI systems to provide patients with information regarding their health condition and treatment methods. The use of medical devices equipped with AI creates new types of risk, including the risk of algorithmic error, the risk of cyber-attack, and the risk of algorithmic mismatch (false-positive or false-negative results). Most patients do not know these tools, so not everyone will trust them. Obtaining informed consent from the patient is a necessary condition for any medical intervention. This study attempts to answer the following questions: (1) Is there a legal possibility to provide AI with the ability to inform the patient about their health condition and proposed treatment methods?; (2) Does the unpredictability and opacity of AI behavior affect the scope of information that should be provided to the patient before medical intervention?; (3) What information should the physician provide to the patient for this consent to be considered informed?; (4) Should the patient always be informed that AI was involved in the diagnosis or therapeutic process? The presented study uses comparative law methodology. American, Belgian and German law are analysed.
- Is there a legal possibility to provide AI with the ability to inform the patient about his health condition and proposed treatment methods?
- Does the unpredictability and opacity of AI behavior, affect the scope of information that should be provided to the patient before medical intervention?
- What information should the physician provide to the patient for this consent to be considered
informed? - Should the patient always be informed that an AI was involved in the diagnosis or therapeutic process?
The comparative law methodology was used in this study. American, Belgian and German law were analyzed.
Keywords:
AI, informed consent, artificial intelligence, medical AIReferences
Buelens, Wannes. “Robots and AI in the healthcare sector: Potential existing legal safeguards against a(n) (un)justified rear for dehumanisation of the physician-patient relationship.” In Artificial intelligence and the Law, edited by Jan De Bruyne and Cedric Vanleenhove, 539–76 . Cambridge: KU Leuven Centre for IT&IP Law Series, Intersentia, 2021.
Ciechorski, Jan. “Glosa do wyroku Sądu Apelacyjnego w Gdańsku z dnia 28 listopada 2012, V ACA 826/12.” Palestra, no. 1–2 (January/February 2014): 162–7.
Cohen, I. Glenn. “Informed Consent and Medical Artificial Intelligence: What to Tell the Patient?.” The Georgetown Law Journal 108 (May 2020): 1425–69.
Kaźmierczyk, Paweł, ed. Biała Księga AI w praktyce klinicznej. Warszawa: AI w zdrowiu, GRAI, PFSZ, 2022. Accessed May 17, 2023. https://aiwzdrowiu.pl/wp-content/uploads/2022/06/BIA_A-KSIE_GA_AI-W-ZDROWIU_2022.pdf.
Kopeć, Marcin. “Art. 31.” In Ustawa o zawodach lekarza i lekarza dentysty. Komentarz, edited by Elżbieta Buczek, Łukasz Caban, Łukasz Dziamski, Wojciech Grecki, Agata Plichta, Lidia Retkowska-Mika, and Monika Urbańska. Warszawa: Wolters Kluwer 2016. Lex/el.
Kubiak, Rafał. Prawo medyczne. Warszawa: C.H. Beck, 2010.
Nicholson, Price II. “Describing Black-Box Medicine.” Boston University Journal of Science and Technology Law 21, no. 2 (Summer 2015): 347–56.
Ogłodek, Ewa, Danuta Moś, Aleksander Araszkiewicz. “Zasady kontaktu terapeutycznego lekarza z pacjentem.” Zdrowie Publiczne 119, no. 3 (Winter 2009): 331–4.
Patryn, Rafał, and Kiełbasa Sylwia. “Zasady prawno-formalnego postępowania lekarza w kontekście świadomej zgody pacjenta i obowiązku zachowania tajemnicy lekarskiej.” Internetowy Przegląd Prawniczy TBSP UJ, no. 4 (2015): 85–99. Accessed April 24, 2023. https://ruj.uj.edu.pl/server/api/core/bitstreams/9dcdbb53-72ca-48a6-9c91-c9044da91a86/content.
Perni, Subha, Lisa Soleymani Lehmann, Danielle S. Bitterman. “Patients should be informed when AI systems are used in clinical trials.” Nature Medicine 29 (2023): 1890–1. https://doi.org/10.1038/s41591-023-02367-8.
Pickering, Brian. “Trust, but Verify: Informed Consent, AI Technologies, and Public Health Emergencies.” Future Internet 13, no. 5 (May 2021).
Schiff, Daniel, and Jason Borenstein. “How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members?.” AMA Journal of Ethics 21, no. 2 (February 2019): 138–45.
Stychlerz, Anna. “Zakres informacji przekazywanych pacjentowi.” Forum Medycyny Rodzinnej 2, no. 6 (November 2018): 471–3.
Świderska, Małgorzata. Zgoda Pacjenta na zabieg medyczny. Toruń: Dom Organizatora, 2007.
Szpara, Justyna. “Prawo do informacji medycznej w relacjach pacjenta z lekarzem.” Prawo i Medycyna 1, no. 4 (Winter 1999):135–9.
Ursin, Franc, Cristian Timmermann, Marcin Orzechowski, and Florian Steger. “Diagnosing Diabetic Retinopathy With Artificial Intelligence: What Information Should Be Included to Ensure Ethical Informed Consent?.” Frontiers in Medicine 8 (July 2021): 1–6, https://doi.org/10.3389/fmed.2021.695217.
World Health Organization. “Ethics and governance of artificial intelligence for health: WHO guidance,” Geneva 2021. Accessed May 17, 2023. https://www.who.int/publications/i/item/9789240029200.
University of Gdańsk https://orcid.org/0000-0003-2594-1408
